ANALYSING COMPLEX DATA IN THE PHARMACEUTICAL INDUSTRY: THE CASE FOR MULTIVARIATE ANALYSIS

Competency-based medical education (CBME) requires a vigorous and multidimensional assessment system. In order to successfully implement CBME, assessment processes must be continuous and frequent.

This session will discuss current changes in the laboratory testing marketplace and the impact on healthcare. Major trends will be discussed specific to physician practice, reimbursement, government programs, and patient care. Opportunities for clinical laboratories and pathology groups to add value for patients, physicians, payers, and hospitals will be examined. Discuss the basic forces for change present in the national marketplace for clinical laboratory and anatomic pathology testing. Explain the ways basic forces may disrupt existing relationships between laboratories and providers. Highlight management approaches to enable clinical laboratories to deliver high-value testing services to integrated healthcare organizations.

The modern trial strategies of today accommodate for a more modern, patient-focused approaches inclusive of the needs of sites and patients.

When it comes to medical product discovery, development, and delivery, patients need to be front and center but how close (or far away) are we from truly having a system that routinely measures what matters to patients? A panel of industry, regulatory, and patient leaders will discuss what’s next for patient-centered measurement. Panelists will define patient-centered measurement; identify novel strategies for capturing patient-centered outcomes; assess the progress in product development, regulatory approval, and delivery; and address how to advance the science of patient input in a way that fulfills the unmet needs of patients across diseases.